199 related articles for article (PubMed ID: 15201343)
21. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons.
Yagami T; Ueda K; Asakura K; Takasu N; Sakaeda T; Itoh N; Sakaguchi G; Kishino J; Nakazato H; Katsuyama Y; Nagasaki T; Okamura N; Hori Y; Hanasaki K; Arimura A; Fujimoto M
Exp Cell Res; 2003 Nov; 291(1):212-27. PubMed ID: 14597421
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
23. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
24. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma.
Kawai T; Hirose H; Seto Y; Fujita H; Fujita H; Ukeda K; Saruta T
Diabetes Res Clin Pract; 2002 May; 56(2):83-92. PubMed ID: 11891015
[TBL] [Abstract][Full Text] [Related]
25. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
[TBL] [Abstract][Full Text] [Related]
26. Effect of fenofibrate and selective PPARĪ± modulator (SPPARMĪ±), pemafibrate on KATP channel activity and insulin secretion.
Kitamura S; Murao N; Yokota S; Shimizu M; Ono T; Seino Y; Suzuki A; Maejima Y; Shimomura K
BMC Res Notes; 2023 Sep; 16(1):202. PubMed ID: 37697384
[TBL] [Abstract][Full Text] [Related]
27. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Aoun P; Watson DG; Simpkins JW
Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
[TBL] [Abstract][Full Text] [Related]
29. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
30. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
Pizzimenti S; Laurora S; Briatore F; Ferretti C; Dianzani MU; Barrera G
Free Radic Biol Med; 2002 Feb; 32(3):233-45. PubMed ID: 11827749
[TBL] [Abstract][Full Text] [Related]
32. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
[TBL] [Abstract][Full Text] [Related]
33. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
[TBL] [Abstract][Full Text] [Related]
34. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
36. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
37. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
Bernardo A; Ajmone-Cat MA; Levi G; Minghetti L
J Neurochem; 2003 Nov; 87(3):742-51. PubMed ID: 14535956
[TBL] [Abstract][Full Text] [Related]
38. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
Bernardo A; Levi G; Minghetti L
Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells.
Date M; Fukuchi K; Morita S; Takahashi H; Ohura K
Liver Int; 2003 Dec; 23(6):460-6. PubMed ID: 14986820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]